Laboratory testing in pharmacies

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 7, 2010, Pages 943-953

  Lippi, Giuseppe ^a   Plebani, Mario ^b   Favaloro, Emmanuel J ^c   Trenti, Tommaso ^d  

^a UNIVERSITY HOSPITAL OF PARMA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c WESTMEAD HOSPITAL   (Australia)

^d AUSL Modena   (Italy)

Author keywords

pharmacy; point of care testing; waived testing

Indexed keywords

DIAGNOSTIC ACCURACY; PATIENT MONITORING; PHARMACY; POINT OF CARE TESTING; PRIORITY JOURNAL; REVIEW; SAMPLING;

HUMANS; PHARMACIES; POINT-OF-CARE SYSTEMS; SOCIAL CONTROL, FORMAL;

EID: 77954224354     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.184     Document Type: Review

References (46)

1. U.S. Department of Health and Human Services, Health Care Finance Administration. Clinical laboratory improvement amendments of 1988, final rule. Federal Register 1992, 7001-7288
2. Commission on Laboratory Accreditation. Laboratory Accreditation Program Point-of-Care Testing Checklist, College of American Pathologists, Oct 31, 2006.
3. U.S. Department of Health and Human Services, National Institutes of Health. Point-of-Care Diagnostic Testing Fact Sheet. Jul 2007.
4. National Institute of Biomedical Imaging and Bioengineering/National Heart, Lung, and Blood Institute/National Science Foundation Workshop Faculty, Price CP, Kricka LJ. Improving healthcare accessibility through point-of-care technologies. Clin Chem 2007;53:1665-1675
5. Gutierres SL, Welty TE. Point-of-care testing: an introduction. Ann Pharmacother 2004;38:119-125
6. Rodis JL, Thomas RA. Stepwise approach to developing pointof-care testing services in the community/ambulatory pharmacy setting. J Am Pharm Assoc (2003) 2006;46:594-604.
7. Chan PC, Rozmanc M, Seiden-Long I, Kwan J. Evaluation of a point-of-care glucose meter for general use in complex tertiary care facilities. Clin Biochem 2009;42:1104-1112
8. Clinical Laboratory Improvement Amendments of 1988, 42 U.S.C. 263a PL100-578.
9. Howerton D, Anderson N, Bosse D, Granade S, Westbrook G. Good Laboratory Practices for Waived Testing Sites. Available at: http://www.cdc.gov/mmwr/ preview/mmwrhtml/rr5413a1.htm. Last accessed: Oct 19, 2009.
10. CLSI, Application of a Quality System Model for Laboratory Services, GP26-A3, 2004.
11. British In Vitro Diagnostics Association. Available at: http://www.bivda.net/. Last accessed: Oct 19, 2009.
12. Gouget B, Barclay J, Rakotoambinina B. Impact of emerging technologies and regulations on the role of POCT. Clin Chim Acta 2001;307:235-240
13. Therapeutic Goods Administration. Overview of the new regulatory framework for in vitro diagnostic medical devices (IVDs), February 2009. Available at: http://www.tga.gov.au/ivd/overview.pdf. Last accessed: Oct 19, 2009.
14. Therapeutic Goods Administration. In vitro diagnostic goods for home-use. Available at: http://www.tga.gov.au/docs/html/ivdhomedr.htm. Last accessed: Oct 19, 2009.
15. Lippi G, Guidi GC, Mattiuzzi C, Plebani M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006;44:358-365
16. Lippi G, Guidi GC. Risk management in the preanalytical phase of laboratory testing. Clin Chem Lab Med 2007;45:720-727
17. Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost 2008;34:612-634
18. Lippi G. Governance of preanalytical variability: travelling the right path to the bright side of the moon? Clin Chim Acta 2009;404:32-36
19. Meier FA, Jones BA. Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Arch Pathol Lab Med 2005;129:1262-1267
20. Lippi G, Blanckaert N, Bonini P, Green S, Kitchen S, Palicka V, et al. Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. Clin Chem Lab Med 2009;47:143-153
21. Fraser CG, Petersen PH. Desirable performance standards for imprecision and bias in alternate sites. The views of laboratory professionals. Arch Pathol Lab Med 1995;119:909-913
22. Fraser CG. Optimal analytical performance for point of care testing. Clin Chim Acta 2001;307:37-43.
23. Ricos C, Alvarez V, Cava F, Garcia-Lario JV, Hernandez A, Jimenez CV, et al. "Current databases on biologic variation: pros, cons and progress." Scand J Clin Lab Inv 1999;59:491-500.
24. Shephard MD, Gill JP. The analytical quality of point-of-care testing in the 'QAAMS' model for diabetes management in Australian Aboriginal medical services. Clin Biochem Rev 2006;27:185-190
25. Wood WG. Problems and practical solutions in the external quality control of point of care devices with respect to the measurement of blood glucose. J Diabetes Sci Technol 2007;1: 158-163
26. Richardson H, Gun-Munro J, Petersons A, Webb S. External quality assessment in the quality management of POCT. Point Care 2005;4:164-166
27. Thomas MA, Sall A, Perkins M, Blount N, Ducroq DH. An external quality assessment scheme for point of care testing in high street pharmacies-the UK model. Clin Chem Lab Med 2009;47(Suppl):S324.
28. Kitchen DP, Kitchen S, Jennings I, Woods T, Walker I. Quality assessment in point-of-care coagulation testing. Semin Thromb Hemost 2008;34:647-653
29. The Royal College of Pathologists of Australasia. POCT-INR EQA proficiency program. Available at: http://www.rcpaqap. com.au/haematology/ infopages/haem-poc.cfm. Last accessed Oct 19, 2009.
30. Spannagl M, Dick A, Reinauer H. External quality assessment schemes in coagulation in Germany: between regulatory bodies and patient outcome. Semin Thromb Hemost 2007;33:259-264
31. Steindel SJ, Granade S, Lee J, Avery G, Clarke LM, Jenny RW, et al. Practice patterns of testing waived under the clinical laboratory improvement amendments. Arch Pathol Lab Med 2002; 126:1471-1479
32. Howerton D, Anderson N, Bosse D, Granade S, Westbrook G. Good Laboratory Practices for Waived Testing Sites. Available at: http://www.cdc.gov/mmwr/ preview/mmwrhtml/rr5413a1.htm. Last accessed: Oct 19, 2009.
33. Plebani M. Does POCT reduce the risk of error in laboratory testing? Clin Chim Acta 2009;404:59-64.
34. Carraro P, Plebani M. Post-analytical errors with portable glucose meters in the hospital setting. Clin Chim Acta 2009;404: 65-67
35. Tighe P. Post-analytical 'error' rates in point-of-care testing: use of a quality assurance programme. Accred Qual Assur 2001;6: 402-404
36. Flobbe K, IJsselmuiden CB, Rheeder P, Gerber JJ, Lubbe M. The pharmacy screening project-an evaluation of pharmacybased screening programmes. S Afr Med J 1999;89:980-986
37. Porter ME, Olmsted Teisberg E. Redefining competition in health care. Harvard Bus Rev 2004;82:64-76.
38. Lippi G, Siest G, Plebani M. Pharmacy-based laboratory services: past or future and risk or opportunity? Clin Chem Lab Med 2008;46:435-436
39. Reder A. Regulating the point of care: the IVD connectivity industry consortium. Med Device Diagn Ind 2001;4:63-73.
40. Handorf CR. Assuring quality in laboratory testing at the point of care. Clin Chim Acta 1997;260:207-216
41. Ehrmeyer SS, Laessig RH. Point-of-care testing, medical error, and patient safety: a 2007 assessment. Clin Chem Lab Med 2007;45:766-773
42. Winkelman JW, Wybenga DR, Tanasijevic MJ. The fiscal consequences of central vs distributed testing of glucose. Clin Chem 1994;40:1628-1630
43. Lee-Lewandrowski E, Laposata M, Eschenback K, Camooso C, Nathan DM, Godine JE, et al. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. Am J Med 1994;97:222-223
44. Nosanchuj JS, Keefner R. Cost analysis of point-of-care laboratory testing in a community hospital. Am J Clin Pathol 1995; 103:240-243
45. Boldt J, Watz G, Triem J, Suttner S, Kumle B. Point-of-care (POC) measurement of coagulation after cardiac surgery. Intensive Care Med 1998;24:1187-1193
46. Kost GJ. Preventing medical errors in point-of-care testing: security, validation, safeguards, and connectivity. Arch Pathol Lab Med 2001;125:1307-1315